Merck & CompanyvsUL Solutions

MRK and ULS stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$146.78

Value $363B

-0.67%
MRK's page

ULS

UL Solutions Inc.

$78.87

Value $15.9B

-1.85%
ULS's page

Merck & Company (MRK) has a market value of $363B and UL Solutions (ULS) $15.9B. Over the last year, with dividends, MRK moved +62.6% and ULS -8.4%. The P/E is 148.0 for MRK and 30.9 for ULS. Dividend yield: MRK 2.32%, ULS 0.72%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$363B

    ULS$15.9B

    MRK is 23 times ULS

  • Revenue, 12 months

    MRK$67.4B

    ULS$3.2B

    MRK is 21 times ULS

  • Net income, 12 months

    MRK$2.5B

    ULS$513M

    MRK is 4.8 times ULS

  • Operating margin

    MRK–

    ULS17.8%

  • ROIC

    MRK3.9%

    ULS21.8%

    17.9 points apart

  • P/E

    MRK148.0

    ULS30.9

    MRK is 4.8 times ULS

  • Dividend yield

    MRK2.3%

    ULS0.7%

    1.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+62.6%

ULS-8.4%

100150DecFebAprJunAugOct
Returns by period
PeriodMRKWith dividendsULSWith dividends
1 year since November 14, 2025+62.6%Price +58.0%-8.4%Price -9.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyULSUL Solutions

Valuation

MRKULS
Valuation
Price$146.78$78.87
Market value$363B$15.9B
Enterprise value (EV)$407B$15.6B
P/E148.030.9
P/E, 5-year median14.8–
P/B8.19.3
EV/EBIT85.527.5
Free cash flow yield4.1%3.0%

Results and growth

MRKULS
Results and growth
Revenue, 12 months$67.4B$3.2B
Net income, 12 months$2.5B$513M
Free cash flow, 12 months$14.7B$481M
Earnings per share, 12 months$0.98$2.52
Revenue growth, year on year1.3%6.4%
Revenue growth a year, past+9.4%over 5 years+6.6%over 3 years
EPS growth a year, past+21.2%over 5 years+2.9%over 3 years

Margins and returns on capital

MRKULS
Margins and returns on capital
Gross margin71.8%50.7%
Operating margin–17.8%
Net margin3.6%16.1%
ROIC3.9%21.8%
ROE5.2%36.3%

Balance sheet

MRKULS
Balance sheet
Cash$9.7B$1.0B
Total debt$53.8B$934M
Net debt / EBITDA5.7-0.3
Interest cover2.4×20.3×

Dividends and buybacks

MRKULS
Dividends and buybacks
Dividend yield2.3%0.7%
Dividend per share, 12 months$3.40$0.57
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%–
Shareholder yield3.7%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or ULS

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or UL Solutions?

By market value, Merck & Company ($363B) is about 22.9 times UL Solutions ($15.9B), at today's prices.

How did MRK and ULS stock do over the last 1 years?

Since November 14, 2025, MRK's price moved +58.0% and ULS's -9.0%. With dividends: MRK +62.6% (+62.6% a year), ULS -8.4% (-8.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or ULS?

The dividend yield at today's price is 2.32% for Merck & Company and 0.72% for UL Solutions. Over the last twelve months they paid $3.40 and $0.57 per share.

What is the P/E of MRK and ULS?

At today's price, the P/E is 148.0 for MRK and 30.9 for ULS. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Merck & Company or UL Solutions?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 16.1% for UL Solutions, and the operating margin – and 17.8%. Revenue was $67.4B and $3.2B.

Which is the better investment, Merck & Company or UL Solutions?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.